Together, genes involved in the pathway, consisting of MTOR, PTEN, PIK3CA, AKT2, and others, have alterations in 26–28% of ccRCC tumours [106, 123]. The gene discussed is PIK3CA; the disease is nonpapillary renal cell carcinoma.